Dogwood Therapeutics, Inc. (DWTX)
1.69
-0.03
(-1.74%)
USD |
NASDAQ |
Sep 18, 16:00
1.70
+0.01
(+0.59%)
After-Hours: 20:00
Dogwood Therapeutics Market Cap : 56.83M for Sept. 18, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 18, 2026 | 56.83M |
| September 17, 2026 | 57.84M |
| September 16, 2026 | 57.17M |
| September 15, 2026 | 58.18M |
| September 14, 2026 | 62.05M |
| September 11, 2026 | 65.24M |
| September 10, 2026 | 63.22M |
| September 09, 2026 | 65.24M |
| September 08, 2026 | 68.60M |
| September 04, 2026 | 77.01M |
| September 03, 2026 | 79.37M |
| September 02, 2026 | 83.40M |
| September 01, 2026 | 88.45M |
| August 31, 2026 | 86.76M |
| August 28, 2026 | 89.12M |
| August 27, 2026 | 78.02M |
| August 26, 2026 | 89.45M |
| August 25, 2026 | 90.13M |
| August 24, 2026 | 86.09M |
| August 21, 2026 | 83.74M |
| August 20, 2026 | 78.36M |
| August 19, 2026 | 77.68M |
| August 18, 2026 | 71.97M |
| August 17, 2026 | 69.28M |
| August 14, 2026 | 72.30M |
| Date | Value |
|---|---|
| August 13, 2026 | 66.59M |
| August 12, 2026 | 64.74M |
| August 11, 2026 | 61.88M |
| August 10, 2026 | 61.12M |
| August 07, 2026 | 60.29M |
| August 06, 2026 | 58.45M |
| August 05, 2026 | 61.12M |
| August 04, 2026 | 59.79M |
| August 03, 2026 | 57.12M |
| July 31, 2026 | 54.78M |
| July 30, 2026 | 52.77M |
| July 29, 2026 | 51.44M |
| July 28, 2026 | 51.77M |
| July 27, 2026 | 51.10M |
| July 24, 2026 | 50.10M |
| July 23, 2026 | 51.44M |
| July 22, 2026 | 48.77M |
| July 21, 2026 | 46.76M |
| July 20, 2026 | 46.09M |
| July 17, 2026 | 46.09M |
| July 16, 2026 | 45.76M |
| July 15, 2026 | 48.10M |
| July 14, 2026 | 47.76M |
| July 13, 2026 | 46.09M |
| July 10, 2026 | 47.43M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.697B |
| Alnylam Pharmaceuticals, Inc. | 32.04B |
| Anika Therapeutics, Inc. | 278.50M |
| Savara, Inc. | 1.103B |
| Vericel Corp. | 2.048B |
Market Cap Related Metrics
| Price to Book Value | 0.8313 |
| Price | 1.69 |
| Earnings Yield | -529.6% |